GMO Pepabo, Inc. provided consolidated earnings guidance for the fiscal year ending December 31, 2022. For the period, the company expected net sales of JPY 11,482 million, operating profit of JPY 1,143 million, profit attributable to owners of parent of JPY 785 million and basic earnings per share of JPY 147.92.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,341 JPY | +0.07% | -1.32% | +14.71% |
Feb. 13 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
Feb. 13 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.71% | 46.28M | |
+25.20% | 434B | |
+18.99% | 250B | |
+12.44% | 144B | |
+17.31% | 101B | |
+23.22% | 88.78B | |
+57.56% | 58.93B | |
+15.09% | 46.54B | |
+4.39% | 37.25B | |
+20.16% | 35.9B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022